Cohance Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.8%1-day move

₹307.95

prior close

₹309.95

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-2.1-2.5-2.9-3.4-2.8+0.5+3.9+21.2+16.3+16.9+58.7+56.6+37.6+46.1

Up moveDown movePending

AI summary

Cohance Lifesciences has submitted a routine compliance certificate to BSE and NSE for the quarter ended March 31, 2026. The certificate, issued by KFin Technologies (the company's Registrar and Share Transfer Agent), confirms under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 that details of all shares dematerialized and rematerialized during the quarter have been reported to both NSDL and CDSL as well as the stock exchanges. This is a standard quarterly compliance filing with no reference to any business, financial, or shareholding changes.

Likely market impact

This is a routine regulatory filing with no material impact on the company, its operations, or its stock price. It simply fulfils a mandatory quarterly reporting requirement regarding share dematerialization activity.